Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Dxcover Limited

News headline image
Dxcover Launches US Operations to Commercialize Its AI-Powered Multiomic Cancer Detection Test
From Dxcover Limited
Via Business Wire
News headline image
Dxcover announces global presentation of first real-world evidence demonstrating that increased tumor size is associated with higher mortality in patients with brain cancer
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Accelerates Growth With New Funding Round and Strengthens the Leadership Team
From Dxcover Limited
Via Business Wire
News headline image
Dxcover names first US Scientific Advisory Board Member
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Multi-Omic Cancer Early Detection Platform Recognized by Academy of Diagnostics & Laboratory Medicine for Scientific Excellence
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Ltd Joins in Recognizing July 17 2024 as #GBMDay in the US
From Dxcover Limited
Via Business Wire
News headline image
May is Brain Cancer Awareness Month
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Early Cancer Detection Platform Founder & CEO Professor Matt Baker Featured Panelist at Global EIE24 Meeting
From Dxcover Limited
Via Business Wire
News headline image
Dxcover invited to present its CREATE-2 clinical trial for the early detection of colorectal cancer and advanced adenoma at the American Association for Cancer Research Annual Meeting 2024 in San Diego CA April 10
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Announces Three New Clinical Trials for Brain, Colorectal and Lung Cancer Detection
From Dxcover Limited
Via Business Wire
News headline image
Dxcover To Present at BIOTECH SHOWCASE™ 2024
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Announces Updates to Executive Leadership Team
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Awarded First Prize for Poster at ESMO 2023 With Multi-Omic Spectral Analysis in Early Detection of Multiple Cancers Data
From Dxcover Limited
Via Business Wire
News headline image
Benefits of Multi-Omic Spectral Analysis in Early Detection of Multiple Cancers Dxcover Study Published in the British Journal of Cancer
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Announces Expansion of Its Leadership Team to Support Advancement of its Multi-Cancer Liquid Biopsy Platform
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Presents Data on Liquid Biopsy Platform for Early Colorectal Cancer Detection at 2023 American Association for Cancer Research (AACR) Annual Meeting
From Dxcover Limited
Via Business Wire
News headline image
Dxcover to Present New Data on Liquid Biopsy Platform at the 2023 American Association for Cancer Research (AACR) Annual Meeting
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Raises $11.9m in Series A and Grant Funding to Accelerate Liquid Biopsy to Market
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Secures Grant from the European Innovation Council to Further Develop Platform for Early Cancer Detection Using Infrared Spectroscopy
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Publishes Research Highlighting Effective Early Detection of Pancreatic Cancer Using Infrared Spectroscopy
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Launches Infrared Platform: Ground-Breaking Technology for Faster Sample Analysis
From Dxcover Limited
Via Business Wire
News headline image
Dxcover Presents Data on Benefits of Spectroscopic Liquid Biopsy for Multi-Cancer Early Detection at ASCO 2022
From Dxcover Limited
Via Business Wire
News headline image
Dxcover to Release New Data on Early Detection Liquid Biopsy for Multiple Cancer Types at 2022 ASCO Annual Meeting
From Dxcover Limited
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.